Tae Heum Jeong insider trades: Rexahn Pharmaceuticals (RNN) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Tae reports to the SEC
Open-market buys and sales
3 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jan 12, 2015 | RNN | ↓ Sell | 317,272 | $0.91 | $289K | Direct | Jan 12, 2015 (0d) |
| Sep 9, 2013 | RNN | ↓ Sell | 71,139 | $0.46 | $32K | Direct | Sep 11, 2013 (2d) |
| Apr 22, 2008 | RXHN.OB | ↑ Buy | 5,000 | $2.26 | $11K | Simple IRA | Apr 23, 2008 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Tae Heum Jeong's insider trades
Tae Heum Jeong is Chief Financial Officer at Rexahn Pharmaceuticals (RNN). Since Apr 22, 2008, Tae has reported 1 open-market purchase worth $11K and 2 sales worth $322K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (11 filings), option exercises (2 filings), shares withheld for taxes (1 filing), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every RNN insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.